Oxy Capital
Overview
Oxy Capital is an alternative asset management firm founded in 2011, with headquarters in Lisbon, Portugal. The firm invests across various business sectors, focusing on private equity, mezzanine debt, restructuring, and public market opportunities. The firm seeks to invest in B2B, B2C, information technology, forestry, energy, manufacturing, industrials, clean technology, restaurant technology & SaaS sectors based in Italy & Portugal regions.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sword Health | Jun 2025 | Growth Equity | Co-investor |
| Feedzai | Oct 2025 | Series E | Co-investor |
| Nonius | Sep 2015 | Buyout/LBO | Lead |
Key People
Enrico Luciano
Managing Partner
Guilherme Valadares Carreiro
Partner
Igor Pereira
Partner
Marco Henriques
Partner
Pedro Sousa
Partner
Tomás Castro de Sá
Partner
Bavieche Samgi
Private Equity Principal
Miguel Bicker Realista
Principal, Member Of Investment Committee
Tânia Teixeira
Head Of KYC & Investor Onboarding
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Oxy Capital based?
Oxy Capital is headquartered in Lisbon, Lisbon, Portugal.
When was Oxy Capital founded?
Oxy Capital was founded in 2011.
How many portfolio companies does Oxy Capital have?
Oxy Capital has 3 portfolio companies in Caplight's dataset.
What are some companies in Oxy Capital's portfolio?
Portfolio companies visible on Caplight include Sword Health, Feedzai, Nonius.
What was Oxy Capital's most recent investment shown here?
Oxy Capital's most recent investment in this portfolio sample was in Feedzai in 2025.
What sectors does Oxy Capital focus on?
Oxy Capital focuses on Healthcare & Life Sciences, FinTech, Enterprise Software, Cybersecurity, Telecommunications & Networking, Enterprise Software.
What company stages does Oxy Capital focus on?
Oxy Capital typically invests at the Late stage.
What is Oxy Capital's AUM?
Oxy Capital's assets under management are estimated between $1.0B and $10.0B.